eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2021
vol. 8
 
Share:
Share:
abstract:
Case report

Hereditary angioedema type III – case report

Katarzyna Waligóra-Dziwak
1
,
Magdalena Woźniak
1
,
Dorota Jenerowicz
1
,
Zygmunt Adamski
1
,
Magdalena Czarnecka-Operacz
1

1.
Katedra i Klinika Dermatologii, Uniwersytet Medyczny w Poznaniu, Polska
Alergologia Polska – Polish Journal of Allergology 2021; 8, 1: 40–47
Online publish date: 2021/03/23
View full text Get citation
 
PlumX metrics:
Hereditary angioedema (HAE) is a genetically determined disease characterized by recurrent episodes of subcutaneous or submucosal tissue oedema. Failure to respond to the classical treatment of angioedema with antihistamines, glucocorticosteroids as well as adrenaline is highly characteristic for HAE. Three main types of HAE have been described: type I – associated with hereditary reduction of C1 esterase inhibitor plasma concentration, type II – associated with its dysfunction and type III with both C1 inhibitor concentration and activity being within the normal range. We present a case report of a 16-year-old female patient with chronic spontaneous angioedema with normal activity and concentration of C1 inhibitor as well as an updated review of the current knowledge concerning pathophysiology, clinical picture, genetic background and possible treatment options for HAE type III.
keywords:

hereditary angioedema, HAE type III, bradykinin, tranexamic acid




Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.